Brittany Bagley, the Chief Operating Officer and Chief Financial Officer of Axon Enterprise, Inc., has recently disposed of a significant number of shares in the company. This transaction, filed on November 17, 2026, reveals a strategic decision regarding her stock ownership and related tax obligations.
The filing indicates that Bagley disposed of 1,003.932 shares of Axon’s common stock on November 13, 2026. The shares were sold at a price of $315.43 each, leading to a notable transaction value. Following this transaction, Bagley retains ownership of approximately 120,681.39 shares of the company.
The filing clarifies that the securities disposed of were withheld to settle Bagley’s tax liability resulting from the vesting of restricted stock units. This practice is common among executives, as it allows them to manage tax obligations while maintaining a stake in the company.
Axon Enterprise, known for its innovations in law enforcement technology, operates within the ordnance and accessories sector. The company is recognized for its commitment to enhancing public safety through advanced technology solutions. As such, management decisions regarding stock ownership can have implications for investor confidence and market perceptions.
Bagley's actions may influence how investors view executive management's commitment to the company, especially in a competitive industry where transparency and accountability are critical. Other companies in the ordnance and accessories sector may observe these developments closely, as they reflect broader trends in executive compensation and stock management.
The filing does not specify any upcoming actions or further disclosures related to this transaction, leaving investors and analysts to interpret the implications of Bagley’s decisions on the company’s future.
Read Next
Corporación América Airports releases Q3 financial results
ITG, Inc. Director Acquires 3,500 Shares of Stock
Century Therapeutics CEO Reports Sale of 31,172 Shares
Axon Enterprise CFO Jennifer H. Mak Disposes of Shares
Rothblatt Reports Major Stock Transactions at United Therapeutics
Gogi Aalia Nighat acquires restricted stock units in Coty




